GlaxoSmithKline Pharmaceuticals Limited
GlaxoSmithKline Pharmaceuticals research, manufacture and make available a broad range of medicines and vaccines that benefit people.(Source : Company Web-site)
What GlaxoSmithKline files
- Others98
- Investor Meet25
- Updates20
- Important16
- Board Meeting12
- Dividend/Bonus9
GlaxoSmithKline Pharmaceuticals (GSK) has set May 29, 2026, as the record date for its final dividend. Shareholders owning GSK shares on this date will be eligible for a dividend of Rs. 57 per share. This dividend distribution is contingent on approval at the Annual General Meeting, scheduled for June 30,...
The Board has approved a proposal for a final dividend of Rs. 57 per equity share for the fiscal year. This significant payout awaits shareholder approval at the upcoming Annual General Meeting. Investors holding shares by the designated record date will be eligible for the dividend, with payments expected to...
GlaxoSmithKline Pharmaceuticals has announced a board meeting on the financial results for the quarter and half-year. The board has proposed a final dividend of Rs. 42 per share, up from Rs. 32 last year, pending shareholder approval. Record and payment dates are set to ensure timely payout. The company posted...
GlaxoSmithKline Pharmaceuticals has announced a board meeting on 30th May 2025 as the record date to identify shareholders eligible for a final dividend of Rs. 42 per equity share (face value Rs. 10) for the year ended 31st March 2025, pending approval at the AGM on 27th June 2025. Dividend...
GlaxoSmithKline Pharmaceuticals has announced a final dividend of Rs. 42 per share, up from Rs. 32 last year, pending shareholder approval. The record date for entitlement is set, with payment to follow. The company posted standalone FY profit of Rs. 919 Cr and consolidated profit of Rs. 928 Cr, signaling...